Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros

Base de dados
País/Região como assunto
Ano de publicação
Tipo de documento
Intervalo de ano de publicação
1.
J Public Health (Oxf) ; 39(3): 574-582, 2017 09 01.
Artigo em Inglês | MEDLINE | ID: mdl-27613767

RESUMO

Introduction: Coronary heart disease (CHD) remains a leading cause of UK mortality. Dietary trans fats (TFA) represent a powerful CHD risk factor. However, UK efforts to reduce intake have been less successful than other nations. We modelled the potential health and economic effects of eliminating industrial and all TFA up to 2020. Methods: We extended the previously validated IMPACTsec model, to estimate the potential effects on health and economic outcomes of mandatory reformulation or a complete ban on dietary TFA in England and Wales from 2011 to 2020. We modelled two policy scenarios: 1) Elimination of industrial TFA consumption, from 0.8% to 0.4% daily energy 2) Elimination of all TFA consumption, from 0.8% to 0. Results: Elimination of industrial TFA across the England and Wales population could result in approximately 1600 fewer deaths per year, with some 4000 fewer hospital admissions; gaining approximately 14 000 additional life years. Health inequalities would be substantially reduced in both scenarios. Elimination of industrial TFA would be cost saving. This would include approximately £100 m saved in direct healthcare costs. Elimination of all TFA would double the health and economic gains. Conclusions: Eliminating industrial or all UK dietary intake of TFA could substantially reduce CHD mortality and inequalities, while resulting in substantial annual savings.


Assuntos
Gorduras na Dieta/administração & dosagem , Ácidos Graxos trans/administração & dosagem , Doença das Coronárias/economia , Doença das Coronárias/mortalidade , Doença das Coronárias/prevenção & controle , Análise Custo-Benefício , Inglaterra , Indústria Alimentícia/economia , Gastos em Saúde/estatística & dados numéricos , Humanos , Modelos Econômicos , Fatores Socioeconômicos , País de Gales
2.
BMJ ; 351: h4583, 2015 Sep 15.
Artigo em Inglês | MEDLINE | ID: mdl-26374614

RESUMO

OBJECTIVES: To determine health and equity benefits and cost effectiveness of policies to reduce or eliminate trans fatty acids from processed foods, compared with consumption remaining at most recent levels in England. DESIGN: Epidemiological modelling study. SETTING: Data from National Diet and Nutrition Survey, Low Income Diet and Nutrition Survey, Office of National Statistics, and health economic data from other published studies PARTICIPANTS: Adults aged ≥25, stratified by fifths of socioeconomic circumstance. INTERVENTIONS: Total ban on trans fatty acids in processed foods; improved labelling of trans fatty acids; bans on trans fatty acids in restaurants and takeaways. MAIN OUTCOME MEASURES: Deaths from coronary heart disease prevented or postponed; life years gained; quality adjusted life years gained. Policy costs to government and industry; policy savings from reductions in direct healthcare, informal care, and productivity loss. RESULTS: A total ban on trans fatty acids in processed foods might prevent or postpone about 7200 deaths (2.6%) from coronary heart disease from 2015-20 and reduce inequality in mortality from coronary heart disease by about 3000 deaths (15%). Policies to improve labelling or simply remove trans fatty acids from restaurants/fast food could save between 1800 (0.7%) and 3500 (1.3%) deaths from coronary heart disease and reduce inequalities by 600 (3%) to 1500 (7%) deaths, thus making them at best half as effective. A total ban would have the greatest net cost savings of about £265m (€361m, $415m) excluding reformulation costs, or £64m if substantial reformulation costs are incurred outside the normal cycle. CONCLUSIONS: A regulatory policy to eliminate trans fatty acids from processed foods in England would be the most effective and equitable policy option. Intermediate policies would also be beneficial. Simply continuing to rely on industry to voluntary reformulate products, however, could have negative health and economic outcomes.


Assuntos
Doença das Coronárias/prevenção & controle , Ácidos Graxos trans/efeitos adversos , Adulto , Doença das Coronárias/economia , Doença das Coronárias/mortalidade , Doença das Coronárias/fisiopatologia , Redução de Custos , Análise Custo-Benefício , Inglaterra , Manipulação de Alimentos , Humanos , Legislação sobre Alimentos , Anos de Vida Ajustados por Qualidade de Vida , Fatores Socioeconômicos
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA